 |
MELBOURNE, Australia and INDIANAPOLIS, Ind., Jan. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides an update on its commercial and operational performance for the quarter ended 31 December 2025 (Q4 2025).
Q4 2025 Highlights
Hashtag.net.au
For many Australians living with a disability, maintaining a clean and safe home can be challenging. Everyday cleaning tasks-like vacuuming, mopping, sanitising kitchens, or bathrooms-may pose physica...
Hashtag.net.au
Access to dependable primary healthcare is essential for maintaining long-term wellbeing. Choosing a trusted GP Bundoora allows individuals and families to receive ongoing medical support close to h...
Hashtag.net.au
The role of a support coordinator is often mentioned in NDIS conversations, but it isn’t always clearly understood. Many participants wonder what a support coordinator actually does day to day, and ho...